SMBC Nikko downgraded Jounce Therapeutics to Neutral from Outperform.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on JNCE:
- Jounce, Redx Pharma announce recommended all share merger transaction
- Jounce downgraded to Market Perform from Outperform at Raymond James
- Redx and Jounce Announce Recommended Business Combination
- Jounce Therapeutics Announces Restructuring
- Jounce Therapeutics to reduce workforce by 57%
Questions or Comments about the article? Write to editor@tipranks.com